Pillstats
Rx only · Tablet, Orally Disintegrating · Oral

Alprazolam

Alprazolam

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US8 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)596
US makers2 labelers
Packages8
DEA / ScheduleCIV

US acquisition costNADAC · per unit

Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.380$0.760$1.14$1.52Dec 2025Apr 2026Jul 2026
$1.321
Latest avg · Jul 22, 2026
+2%
Since Dec 17, 2025
2
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

5331.1K1.6K2.1K2025 Q12025 Q22025 Q32025 Q42026 Q1
1.7K
Rx · 2026 Q1
69K
Units dispensed
-6%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Actavis Pharma, Inc.unknown4SUPPLYING
Par Health USA, LLCunknown4SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Oct 9, 2013
    RECALLRecall (Class II): Alprazolam Orally Disintegrating Tablets, USP 2 mg, 100 count bottles, Rx Only, MFG. BY ACTAVIS ELIZABETH LLC., Elizabe…

    Failed Tablet/Capsule Specifications; partial tablet erosion resulting in tablet weights below specification in some tablets — Recalling firm: Actavis Elizabeth LLC — Nationwide